Copyright
©The Author(s) 2024.
World J Hepatol. Mar 27, 2024; 16(3): 428-438
Published online Mar 27, 2024. doi: 10.4254/wjh.v16.i3.428
Published online Mar 27, 2024. doi: 10.4254/wjh.v16.i3.428
Outcomes | LTAD (n = 30) | LVP (n = 19) | P value |
Median survival, d | 124 (330) | 297 (438) | 0.06 |
Median follow-up (with drain in place/undergoing LVP), d | 135 (226) | 80 (239) | 0.98 |
Ascites/drain related admissions | 11 (37) | 17 (89) | 0.004 |
Time to first hospitalisation, (IQR), d | 44 (93) | 10 (35) | 0.002 |
AKI | 8 (27) | 11 (58) | 0.014 |
Drain-related complications | 14 (47) | 11 (58) | 0.06 |
Patients with peritonitis | 5 (17) | 5 (26) | 0.46 |
Total No. of peritonitis episodes | 10 (33) | 5 (26) | 0.98 |
Cellulitis | 4 (13) | 2 (10) | 1.00 |
Site leakage | 12 (40) | 2 (10) | 0.10 |
Bleeding of drain site | 2 (7) | 1 (5) | 1.00 |
Hypotension | 6 (20) | 4 (21) | 0.71 |
- Citation: Kaur S, Motta RV, Chapman B, Wharton V, Collier JD, Saffioti F. Palliative long-term abdominal drains vs large volume paracenteses for the management of refractory ascites in end-stage liver disease. World J Hepatol 2024; 16(3): 428-438
- URL: https://www.wjgnet.com/1948-5182/full/v16/i3/428.htm
- DOI: https://dx.doi.org/10.4254/wjh.v16.i3.428